A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer - Contacts and Locations

Home

A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer

This study has been completed.

Study NCT00073541. Last updated on November 7, 2007. Information provided by EMD Pharmaceuticals

Please refer to this study by its ClinicalTrials.gov identifier: NCT00073541

Locations


United States, Maryland

	Baltimore, Maryland, United States

United States, Massachusetts

	Boston, Massachusetts, United States

United States, New York

	New York, New York, United States

United States, North Carolina

	Charlotte, North Carolina, United States

United States, Tennessee

	Nashville, Tennessee, United States

Sponsors and Collaborators

EMD Pharmaceuticals

Merck KGaA